AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2017
Sep 7, 2017
30786_dirs_2017-09-06_04bfd220-9f18-48de-9711-cef668f78b51.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2017-09-05
Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-05 | Restricted Stock Units | $0 | A | 13000 | Acquired | Bio-Rad A Common Stock (13000) | Direct | |
| 2017-09-05 | Non-Qualified Stock Option (right to buy) | $215.98 | A | 13000 | Acquired | 2027-09-05 | Bio-Rad A Common Stock (13000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 411252 | Direct |
| Bio-Rad B Common Stock | 12664 | Indirect |
| Bio-Rad B Common Stock | 4060054 | Indirect |
| Bio-Rad B Common Stock | 236451 | Direct |
Footnotes
F1: The reporting person disclaims beneficial ownership of these shares.
F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.
F5: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.